<!DOCTYPE html><html lang="en"><head><title>Static News</title><meta charSet="utf-8"/><meta name="description" content="Static delayed Hacker News."/><meta name="theme-color" media="(prefers-color-scheme: light)" content="white"/><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1d1f21"/><meta name="viewport" content="width=device-width,initial-scale=1.0"/><meta name="application-name" content="Static News"/><meta name="apple-mobile-web-app-title" content="Static News"/><meta name="apple-mobile-web-app-capable" content="yes"/><meta name="mobile-web-app-capable" content="yes"/><meta name="apple-mobile-web-app-status-bar-style" content="#1d1f21"/><link rel="preload" href="styles.css?v=1734685260945" as="style"/><link rel="stylesheet" href="styles.css?v=1734685260945"/></head><body><div id="container"><div id="inner"><header><a href="/">Static News</a><a href="/about">about</a></header><div id="content"><div><div id="title"><a href="https://www.writingruxandrabio.com/p/on-clinical-trial-abundance">How to Test More Drugs</a> <span class="domain">(<a href="https://www.writingruxandrabio.com">www.writingruxandrabio.com</a>)</span></div><div class="subtext"><span>apsec112</span> | <span>9 comments</span></div><br/><div><div id="42468527" class="c"><input type="checkbox" id="c-42468527" checked=""/><div class="controls bullet"><span class="by">vonnik</span><span>|</span><a href="#42468367">next</a><span>|</span><label class="collapse" for="c-42468527">[-]</label><label class="expand" for="c-42468527">[3 more]</label></div><br/><div class="children"><div class="content">Rux ignores one of the main bottlenecks of clinical trials: finding the clinical trial managers whose expertise is necessary to manage them and surface candidates for them. Pharma would run as many trials as there are managers. And managers themselves could run trials more quickly if it was easy to find good candidate matches for a trial. LLMs are beginning to help them solve the problem of candidate discovery, since the right patients need to be a high dimensional match, and their fitness can only be discovered by perusing their EHRs for hours.</div><br/><div id="42469327" class="c"><input type="checkbox" id="c-42469327" checked=""/><div class="controls bullet"><span class="by">eddsolves</span><span>|</span><a href="#42468527">parent</a><span>|</span><a href="#42468958">next</a><span>|</span><label class="collapse" for="c-42469327">[-]</label><label class="expand" for="c-42469327">[1 more]</label></div><br/><div class="children"><div class="content">Can you ELI5 how LLMs help there?</div><br/></div></div><div id="42468958" class="c"><input type="checkbox" id="c-42468958" checked=""/><div class="controls bullet"><span class="by">forgetfreeman</span><span>|</span><a href="#42468527">parent</a><span>|</span><a href="#42469327">prev</a><span>|</span><a href="#42468367">next</a><span>|</span><label class="collapse" for="c-42468958">[-]</label><label class="expand" for="c-42468958">[1 more]</label></div><br/><div class="children"><div class="content">There is also the minor issue of private equity sucking the air out of the goddamn room for orphan&#x2F;rare indications. Losing count of the number of investigators that have had their parent orgs purchased by PE firms which then inflate trial fees to the point that they fail BADLY in industry benchmarking software with no rationale provided for the increase and no recourse available. Waiting impatiently for the carnival of bullshit that&#x27;s going to kick off the first time the OIG flags this shit as a false(?) positive for overt corruption.</div><br/></div></div></div></div><div id="42468367" class="c"><input type="checkbox" id="c-42468367" checked=""/><div class="controls bullet"><span class="by">dang</span><span>|</span><a href="#42468527">prev</a><span>|</span><a href="#42469273">next</a><span>|</span><label class="collapse" for="c-42468367">[-]</label><label class="expand" for="c-42468367">[1 more]</label></div><br/><div class="children"><div class="content">Recent and related:<p><i>The Case for Clinical Trial Abundance</i> - <a href="https:&#x2F;&#x2F;ifp.org&#x2F;the-case-for-clinical-trial-abundance&#x2F;" rel="nofollow">https:&#x2F;&#x2F;ifp.org&#x2F;the-case-for-clinical-trial-abundance&#x2F;</a><p>(via <a href="https:&#x2F;&#x2F;news.ycombinator.com&#x2F;item?id=42462904">https:&#x2F;&#x2F;news.ycombinator.com&#x2F;item?id=42462904</a>, but no comments there)</div><br/></div></div><div id="42469273" class="c"><input type="checkbox" id="c-42469273" checked=""/><div class="controls bullet"><span class="by">refurb</span><span>|</span><a href="#42468367">prev</a><span>|</span><a href="#42468805">next</a><span>|</span><label class="collapse" for="c-42469273">[-]</label><label class="expand" for="c-42469273">[1 more]</label></div><br/><div class="children"><div class="content">The message needs to be honed.<p>Subtitle of “More trials, not laxer standards” then gives an example of RBM where in-person site visits and comprehensive data validation are replaced by digital “checks”.<p>Ok, so “laxer standards” it is!<p>The key is knows which standards can be more lax without jeopardizing patient safety.<p>But I agree with the idea of the FDA incentivizing sponsors to leverage cost and time saving technologies.  They often won’t do it themselves (or at least not quickly), but the FDA is in an ideal position to incentivize it.</div><br/></div></div><div id="42468805" class="c"><input type="checkbox" id="c-42468805" checked=""/><div class="controls bullet"><span class="by">pr337h4m</span><span>|</span><a href="#42469273">prev</a><span>|</span><label class="collapse" for="c-42468805">[-]</label><label class="expand" for="c-42468805">[3 more]</label></div><br/><div class="children"><div class="content">just abolish the fda. your body your choice. private organizations can evaluate the efficacy and safety of various drugs and issue voluntary guidelines aimed at patients, doctors, and insurers.</div><br/><div id="42469250" class="c"><input type="checkbox" id="c-42469250" checked=""/><div class="controls bullet"><span class="by">dools</span><span>|</span><a href="#42468805">parent</a><span>|</span><a href="#42468888">next</a><span>|</span><label class="collapse" for="c-42469250">[-]</label><label class="expand" for="c-42469250">[1 more]</label></div><br/><div class="children"><div class="content">Not sure if RFK satire or genuine ancap point of view</div><br/></div></div><div id="42468888" class="c"><input type="checkbox" id="c-42468888" checked=""/><div class="controls bullet"><span class="by">seattle_spring</span><span>|</span><a href="#42468805">parent</a><span>|</span><a href="#42469250">prev</a><span>|</span><label class="collapse" for="c-42468888">[-]</label><label class="expand" for="c-42468888">[1 more]</label></div><br/><div class="children"><div class="content">That&#x27;s how the supplements industry works now. They&#x27;re almost entirely snake-oil and scams.</div><br/></div></div></div></div></div></div></div></div></div></body></html>